🕵️ Biodexa Pharmaceuticals PLC ($BDRX)
SEC insider & ownership activity, last 12 months · CIK 1643918 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Sabby Management, LLC | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Hal Mintz | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 13G | Jan 20, 2026 | filing ↗ | |
| C/M Capital Partners, LP | 5.7% | 13G | May 28, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.